LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Kodu・Aktsiate loetelu・Boston Scientific Corp.

Boston Scientific Corp.

Suletud

Sektor Tervishoid

81.59 0.31

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

81.29

Max

81.65

Põhinäitajad
By Trading Economics
Sissetulek	-168M 324M
Müük	260M 4.1B
P/E Sektori keskmine	64.71 103.001
Aktsiakasum	0.62
Kasumimarginaal	7.864
Töötajad	48,000
EBITDA	-173M 808M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+7.67 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. okt 2024

Turustatistika
By TradingEconomics
Turukapital	617M 120B
Eelmine avamishind	81.28
Eelmine sulgemishind	81.59

Uudiste sentiment

By Acuity

30%

70%

56 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

79.9 / 81.79 Toetus ja vastupanu

Boston Scientific Corp. Graafik

Seotud uudised

18. juuni 2024, 13:23 UTC

Omandamised, ülevõtmised, äriostud

Correction to Boston Scientific to Buy Silk Road Article

18. juuni 2024, 11:41 UTC

Suurimad hinnamuutused turgudel

Omandamised, ülevõtmised, äriostud

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18. juuni 2024, 11:31 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24. apr 2024, 11:01 UTC

Tulu

Boston Scientific Lifts 2024 Outlook After Strong 1Q

24. juuli 2024, 12:02 UTC

Tulu

Boston Scientific Earnings Beat; Medtech Giant Raises Guidance -- IBD

24. juuli 2024, 10:48 UTC

Tulu

Boston Scientific Profit Beats Estimates As Cardiovascular Sales Surge -- MarketWatch

24. juuli 2024, 10:47 UTC

Tulu

GE Vernova Delivers An Earnings Beat With First Results After Separation, Even As Revenue Misses -- MarketWatch

24. juuli 2024, 10:47 UTC

Tulu

Boston Scientific Earnings Beat, Guidance Raised; Medtech Giant Rises -- IBD

24. juuli 2024, 10:33 UTC

Tulu

Boston Scientific Sees 3Q Net Sales Growth of About 13%-15% >BSX

24. juuli 2024, 10:32 UTC

Tulu

Boston Scientific Sees FY Net Sales Growth of About 13.5%-14.5% >BSX

24. juuli 2024, 10:30 UTC

Tulu

Boston Scientific Sees FY EPS $1.34-EPS $1.38 >BSX

24. juuli 2024, 10:30 UTC

Tulu

Boston Scientific Sees FY Adj EPS $2.38-Adj EPS $2.42 >BSX

24. juuli 2024, 10:30 UTC

Tulu

Boston Scientific 2Q Adj EPS 62c >BSX

24. juuli 2024, 10:30 UTC

Tulu

Boston Scientific 2Q EPS 22c >BSX

24. juuli 2024, 10:30 UTC

Tulu

Boston Scientific Sees 3Q Adj EPS 57c-Adj EPS 59c >BSX

24. juuli 2024, 10:30 UTC

Tulu

Boston Scientific Sees 3Q EPS 36c-EPS 38c >BSX

24. juuli 2024, 10:30 UTC

Tulu

Boston Scientific 2Q Sales $4.12B >BSX

18. juuni 2024, 20:22 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18. juuni 2024, 14:25 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18. juuni 2024, 12:54 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18. juuni 2024, 11:33 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18. juuni 2024, 11:18 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18. juuni 2024, 11:03 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18. juuni 2024, 11:02 UTC

Omandamised, ülevõtmised, äriostud

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18. juuni 2024, 11:01 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18. juuni 2024, 11:01 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18. juuni 2024, 11:00 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24. apr 2024, 12:30 UTC

Peamised uudised

Tulu

Boston Scientific Stock Rises on More Than Just an Earnings Beat -- Barrons.com

24. apr 2024, 10:36 UTC

Tulu

Boston Scientific Sees 2024 Sales Up 11%-13%, Organic Sales Up 10%-12% >BSX

24. apr 2024, 10:35 UTC

Tulu

Boston Scientific Sees 2Q Sales Up 10.5%-12.5%, Organic Sales Up 10%-12% >BSX

Võrdlus sarnastega

Hinnamuutus

Boston Scientific Corp. Prognoos

Hinnasiht

By TipRanks

7.67% tõus

12 kuu keskmine prognoos

Keskmine 87.61 USD 7.67%

Kõrge 100 USD

Madal 78 USD

Põhineb 19 Wall Streeti analüütiku instrumendi Boston Scientific Corp. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

19 ratings

Osta

Hoia

Müü

Põhineb 19 analüütiku instrumendi Boston Scientific Corp. aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

79.9 / 81.79Toetus ja vastupanu

Bullish events outweigh bearish events.

There is one bullish event.

Sentiment

By Acuity

56 / 365 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.